Perioperative nivolumab did not improve RFS in RCC patients at high risk for recurrence

OncoAlert and ecancer weekly round up for August 15th - 21st, 2022

An overview of treatment advances in gastric cancer

Working to improve global cancer care access in low middle-income countries

ASCO Direct Highlights 2022: prostate cancer highlights

ASCO Direct Highlights 2022: lung cancer highlights

War in Ukraine: Global cancer aid to support refugees

War in Ukraine: The International Brain Tumour Alliance's response to aiding refugees during the crisis

ASCO and WHO to collaborate on quality indicators for cancer facilities

Isatuximab, lenalidomide, bortezomib and dexamethasone as induction therapy show a superior MRD negativity rate for newly diagnosed MM patients

Comment: LUMINA results show that women with low levels of the Ki67 biomarker can avoid outcomes related to radiotherapy

Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy